ORCHID PHARMA
Back to Balance Sheet
|
ORCHID PHARMA Last 5 Year Total Debt History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Total Debt | ₹301 Cr | ₹153 Cr | ₹134 Cr | ₹331 Cr | ₹268 Cr |
What is the latest Total Debt ratio of ORCHID PHARMA ?
| Year | Total Debt |
|---|---|
| Mar2026 | ₹301 Cr |
| Mar2025 | ₹153 Cr |
| Mar2024 | ₹134 Cr |
| Mar2023 | ₹331 Cr |
| Mar2022 | ₹268 Cr |
How is Total Debt of ORCHID PHARMA Trending?
| Years | Total Debt | % Change | |
|---|---|---|---|
| Mar2026 | ₹301 Cr | 96.58 | |
| Mar2025 | ₹153 Cr | 14.03 | |
| Mar2024 | ₹134 Cr | -59.41 | |
| Mar2023 | ₹331 Cr | 23.66 | |
| Mar2022 | ₹268 Cr | - | |
Compare Total Debt of peers of ORCHID PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| ORCHID PHARMA | ₹5,939.4 Cr | -6.9% | 4.9% | 35.2% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹434,280.0 Cr | -2.4% | -6.2% | 11.8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹246,737.0 Cr | -3.3% | 1.4% | 57.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹181,129.0 Cr | -4.5% | -4% | 35.9% | Stock Analytics | |
| CIPLA | ₹108,808.0 Cr | -3.6% | -5% | -10.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹100,170.0 Cr | -0.2% | 2.5% | -3% | Stock Analytics | |
ORCHID PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| ORCHID PHARMA | -6.9% |
4.9% |
35.2% |
| SENSEX | -2.3% |
-6.6% |
-12% |
You may also like the below Video Courses